853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US

BACKGROUND: Once-daily oral tenofovir-based combinations as pre-exposure prophylaxis (PrEP) have shown to be an effective biomedical HIV prevention strategy for populations at-risk of acquiring HIV-1. However, low adherence can lead to poor effectiveness. This study described the characteristics of...

Descripción completa

Detalles Bibliográficos
Autores principales: Oglesby, Alan, Germain, Guillaume, Laliberte, Francois, Bush, Staci, Swygard, Heidi, MacKnight, Sean, Hilts, Annalise, Duh, Mei Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644701/
http://dx.doi.org/10.1093/ofid/ofab466.1048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644701/
http://dx.doi.org/10.1093/ofid/ofab466.1048

Ejemplares similares